Expression of CD44v6 has no prognostic value in patients with colorectal cancer.

Jüngling, B; Menges, M; Goebel, R; Wittig, B M; Weg-Remers, S; Pistorius, G; Schilling, M; Bauer, M; König, J; Zeitz, M; Stallmach, A

Jüngling, B; Menges, M; Goebel, R; Wittig, B M; Weg-Remers, S; Pistorius, G; Schilling, M; Bauer, M; König, J; Zeitz, M; Stallmach, A.

Affiliation

Jüngling B; Department of Internal Medicine II, Saarland University, Homburg/Saar, Germany.

Z Gastroenterol ; 40(4): 229-33, 2002 Apr.

Article in En | MEDLINE | ID: mdl-11961731

Subject(s)

Adenocarcinoma/genetics; Colorectal Neoplasms/genetics; Glycoproteins/genetics; Hyaluronan Receptors/genetics; Adenocarcinoma/mortality; Adenocarcinoma/pathology; Adult; Aged; Aged, 80 and over; Colorectal Neoplasms/mortality; Colorectal Neoplasms/pathology; Female; Gene Expression Regulation, Neoplastic/physiology; Humans; Male; Middle Aged; Neoplasm Staging; Prognosis; Survival Rate

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Glycoproteins / Colorectal Neoplasms / Adenocarcinoma / Hyaluronan Receptors Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Z Gastroenterol Year: 2002 Document type: Article

Search on Google

XML

PubMed Links